View Resource Centers
Toggle Dropdown
Multiple Sclerosis
Migraine Research Library
LGS & Dravet Syndrome
Tardive Dyskinesia
Myasthenia Gravis
Neurofibromatosis
hATTR-PN
MDA 2024
CIDP Awareness Month
Alzheimer's Awareness Month
Anticoagulation Reversal Knowledge & Learning Center
PNS 2024 Annual Meeting Highlights
Parkinson's Disease
AES Annual Meeting 2025
Epilepsy Knowledge Hub
Stroke Awareness Month
Multiple Sclerosis
Migraine Research Library
LGS & Dravet Syndrome
Tardive Dyskinesia
Neurofibromatosis
hATTR-PN
MDA 2024
CIDP Awareness Month
Alzheimer's Awareness Month
Anticoagulation Reversal Knowledge & Learning Center
PNS 2024 Annual Meeting Highlights
Parkinson's Disease
Peer-reviewed articles
Supplemental educational content
Test Your Knowledge
AES Annual Meeting 2025
Stroke Awareness Month
Advanced Search
Advanced Search
Featured:
Myasthenia Gravis
Epilepsy Knowledge Hub
Test Your Knowledge
Parkinson's Disease Resource Center Home Page
According to the MDS Clinical Diagnostic Criteria, which of the following is a mandatory prerequisite for diagnosing Parkinson·s disease?
Which of the following features is considered an absolute exclusion criterion in the MDS Clinical Diagnostic Criteria for Parkinson·s disease?
What is the primary purpose of the MDS-UPDRS Part III (Motor Examination)?
Which of the following supportive criteria strengthens the diagnosis of Parkinson·s disease according to the MDS-PD criteria?
A.
Presence of resting tremor
B.
Bradykinesia plus either rigidity or rest tremor
C.
Positive response to levodopa
D.
MRI evidence of substantia nigra degeneration
A.
Symmetric onset of motor symptoms
B.
Early severe autonomic failure
C.
Presence of REM sleep behavior disorder
D.
Positive family history of parkinsonism
A.
To assess non-motor symptoms such as mood and cognition
B.
To evaluate the patient·s quality of life
C.
To quantify motor signs such as tremor, rigidity, and bradykinesia
D.
To determine the patient·s medication adherence
A.
Early falls within the first year
B.
Sustained levodopa responsiveness
C.
Cerebellar signs
D.
Vertical gaze palsy
Submit